Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	50	non-cytoplasmic
51	73	transmembrane
74	80	cytoplasmic
81	100	transmembrane
101	105	non-cytoplasmic
106	128	transmembrane
129	138	cytoplasmic
139	162	transmembrane
163	173	non-cytoplasmic
174	196	transmembrane
197	238	cytoplasmic
239	260	transmembrane
261	271	non-cytoplasmic
272	294	transmembrane
295	305	cytoplasmic
306	324	transmembrane
325	329	non-cytoplasmic
330	349	transmembrane
350	357	cytoplasmic
358	379	transmembrane
380	392	non-cytoplasmic
393	414	transmembrane
415	427	cytoplasmic

Input:
>WP_051249719.1 NCBI__GCF_000425265.1:WP_051249719.1
MSPNIEQVVNKTRLRLIPFMLTLYILAFLDRANIGFAKVSYQMDTGLGDGAFALGAGIFF
VAYAFLGVPANLLMRKFGARAWIGSTTLVWGVLSASMGYADTEWKFLLVRSLLGAAEAGF
FPGMIYLTSQWFPQKSRAGIMGLFYMGAPLALTLGSPLSGALLEMHGFMGHPGWYWMFII
EGALALVAGVATFCYLDDRPSEARFLSQVERDLLQKTLAAEESSKSTSKISDAARNWTVW
HLAIIYMIIQISVYGLVFYLPSQVAALMGTNVGFTASLVTAIPWVAALFGTYYIPRYSDR
TGERRNIAALTLLVAGLGIGISAFASPVVAIVALCFAAAGFIAVQPVFWTMPTGLLSGTA
LAAGIGFTNMFGAFGGFLAPNIKAQADLFFGNHLAGLVSLAIITVIGSITIMMLPKKEAP
RVVLSNA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server